JP2025514774A5 - - Google Patents

Info

Publication number
JP2025514774A5
JP2025514774A5 JP2024561891A JP2024561891A JP2025514774A5 JP 2025514774 A5 JP2025514774 A5 JP 2025514774A5 JP 2024561891 A JP2024561891 A JP 2024561891A JP 2024561891 A JP2024561891 A JP 2024561891A JP 2025514774 A5 JP2025514774 A5 JP 2025514774A5
Authority
JP
Japan
Prior art keywords
cells
nucleic acid
human
pharmaceutical composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025514774A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/065898 external-priority patent/WO2023205644A1/en
Publication of JP2025514774A publication Critical patent/JP2025514774A/ja
Publication of JP2025514774A5 publication Critical patent/JP2025514774A5/ja
Pending legal-status Critical Current

Links

JP2024561891A 2022-04-19 2023-04-18 改変西部ウマ脳炎ウイルス及びその使用 Pending JP2025514774A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263332606P 2022-04-19 2022-04-19
US63/332,606 2022-04-19
PCT/US2023/065898 WO2023205644A1 (en) 2022-04-19 2023-04-18 Modified western equine encephalitis viruses and uses thereof

Publications (2)

Publication Number Publication Date
JP2025514774A JP2025514774A (ja) 2025-05-09
JP2025514774A5 true JP2025514774A5 (cg-RX-API-DMAC7.html) 2026-04-23

Family

ID=88420660

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024561891A Pending JP2025514774A (ja) 2022-04-19 2023-04-18 改変西部ウマ脳炎ウイルス及びその使用

Country Status (9)

Country Link
US (1) US20250257329A1 (cg-RX-API-DMAC7.html)
EP (1) EP4511497A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025514774A (cg-RX-API-DMAC7.html)
KR (1) KR20250024759A (cg-RX-API-DMAC7.html)
CN (1) CN119301261A (cg-RX-API-DMAC7.html)
AU (1) AU2023256639A1 (cg-RX-API-DMAC7.html)
CA (1) CA3256333A1 (cg-RX-API-DMAC7.html)
IL (1) IL316351A (cg-RX-API-DMAC7.html)
WO (1) WO2023205644A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054566A (en) * 1988-02-26 2000-04-25 Biosource Technologies, Inc. Recombinant animal viral nucleic acids
US6261570B1 (en) * 1997-05-20 2001-07-17 The United States Of America As Represented By The Secretary Of The Army Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants
EP3864027A1 (en) * 2018-10-08 2021-08-18 Janssen Pharmaceuticals, Inc. Alphavirus-based replicons for administration of biotherapeutics
JP2023517644A (ja) * 2020-03-09 2023-04-26 アークトゥラス・セラピューティクス・インコーポレイテッド コロナウイルスワクチン組成物及び方法
WO2022009049A1 (en) * 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
AU2021315795A1 (en) * 2020-07-31 2023-02-23 Replicate Bioscience, Inc. Modified Chikungunya viruses and Sindbis viruses and uses thereof

Similar Documents

Publication Publication Date Title
JP7416443B2 (ja) 高形質導入効率rAAVベクター、組成物、および使用方法
KR102409147B1 (ko) 종양분해성 백시니아 바이러스
KR101255016B1 (ko) 소포성 구내염 바이러스의 상승적 감쇠, 그의 벡터 및 그의 면역원성 조성물
CN105849270B (zh) 用于病毒疗法的新型流感病毒载体
CA3188801A1 (en) Rna replicon vaccines against hbv
JPWO2012053646A1 (ja) ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム/ブーストワクチン用ウイルスベクター
US20230398200A1 (en) Modified chikungunya viruses and sindbis viruses and uses thereof
JP2024527345A5 (cg-RX-API-DMAC7.html)
EP2977457B1 (en) Idna vaccines and methods for using the same
US20240327865A1 (en) Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereof
US20240400619A1 (en) Modified alphaviruses with heterologous nonstructural proteins
JP2024535729A5 (cg-RX-API-DMAC7.html)
WO2025157249A1 (zh) 一种自复制rna及其用途
CN118108860B (zh) 一种基于FcRn可提高细胞免疫水平的重组疫苗及应用
CN116904489B (zh) 一种鸭坦布苏病毒核酸疫苗及应用
IL316351A (en) Modified western equine encephalitis viruses and uses thereof
CN101120086A (zh) 用于肿瘤治疗的黄病毒复制子结构
US12558417B2 (en) Hepatitis A virus preparation method and hepatitis A virus prepared according to method
JP2002544236A (ja) 組換えパラポックスウイルスに基づくとりわけ肝の慢性ウイルス感染症ならびに炎症性、変性性および増殖性疾患ならびに癌のための器官、組織および細胞特異的免疫治療薬
JP2024542613A (ja) Il-12及びil-1raの発現のための組成物と方法
WO2024219994A1 (ru) Экспрессионный вектор на основе аденовируса человека 19 серотипа и способ его применения
HK40091626A (en) Rna replicon vaccines against hbv
EA048601B1 (ru) Экспрессионный вектор на основе аденовируса человека 19 серотипа и способ его применения
HK1220720B (en) Idna vaccines and methods for using the same
HK1116831A (en) Flavivirus replicon constructs for tumour therapy